ASO Visual Abstract: Tumor-Infiltrating Lymphocytes (TILs) as a Biomarker of Abscopal Effect of Cryoablation in Breast Cancer-A Pilot Study

被引:1
|
作者
Khan, Sonia Y. [1 ]
Melkus, Michael W. [1 ]
Rasha, Fahmida [2 ]
Castro, Maribel [1 ]
Chu, Victoria [1 ]
Brandi, Luis [3 ]
Khan, Hafiz [4 ]
Gill, Harvinder Singh [5 ]
Pruitt, Kevin [2 ]
Rahman, Rakhshanda Layeequr [1 ,6 ]
机构
[1] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Dept Surg, Lubbock, TX 79430 USA
[2] Texas Tech Univ, Hlth Sci Ctr, Dept Immunol & Mol Microbiol, Lubbock, TX 79430 USA
[3] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Dept Pathol, Lubbock, TX 79430 USA
[4] Texas Tech Univ, Hlth Sci Ctr, Julia Jones Matthews Dept Publ Hlth, Lubbock, TX 79430 USA
[5] Texas Tech Univ, Dept Chem Engn, Lubbock, TX 79409 USA
[6] Texas Tech Univ, Hlth Sci Ctr, Breast Ctr Excellence, Lubbock, TX 79430 USA
关键词
D O I
10.1245/s10434-021-11240-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Morphological evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer is gaining momentum as an immunological biomarker. This experiment evaluates the role of TILs in distant tumors as a measure of abscopal effect from cryoablation of breast cancer. Methods: BALB/c mice underwent bilateral orthotopic transplant with 4T1-12B (triple-negative) cells. At 2 weeks, left tumors were treated by either resection (standard of care group) or cryoablation (intervention group) followed by resection of the distant right tumors 1 week posttreatment. TIL scores were calculated from hematoxylin and eosin-stained sections and phenotyped for cytotoxic T-lymphocyte (CTL) markers by immunofluorescence. Primarily resected tumors served as baseline (Tbaseline), whereas resected distant right-sided served as the readout for abscopal effect (AbsRes or AbsCryo). Mice were monitored for tumor recurrence and metastasis. Results: The AbsCryo had a significant mean (SD) increase in stromal (2.8 [1.1]%; p = 0.015) and invasive margin TILs (50 [12]%; p = 0.02) compared with TBaseline (1.0 [0]% and 31 [4.9]%, respectively). CTL phenotyping revealed a significant increase in mean (SD) CD8+ T cells (15.7 [12.1]; p = 0.02) and granzyme B (4.8 [3.6]; p = 0.048) for the AbsCryo compared with TBaseline (5.2 [4.7] and 2.4 [0.9], respectively). Posttreatment, the cryoablation group had no recurrence or metastasis, whereas the resected group showed local recurrence and lung metastasis in 40% of the mice. Postprocedure increase in TIL score of distant tumors was associated with decrease in tumor relapse (p = 0.02). Conclusions: Cryoablation induced a robust tumor-specific TIL response compared with resection, suggesting an abscopal effect leading to the prevention of cancer recurrence and metastasis. © 2022, The Author(s).
引用
收藏
页码:2928 / 2929
页数:2
相关论文
共 50 条
  • [31] The evaluation of tumor-infiltrating lymphocytes (TILs) in early breast cancer: differences between histologic subtypes in a Portuguese cohort
    Luz, P.
    Fernandes, I.
    Arede, A. J.
    Campoa, E.
    Alves, L.
    Enrique Morera, J. L.
    Gosalbez, B.
    Costa, J. G.
    Fernandes, A.
    BREAST, 2021, 56 : S63 - S63
  • [32] Tumor-infiltrating lymphocytes (TILs) density as prognostic determinant in stage II colorectal cancer
    Ricci, V.
    Comino, A.
    Vivenza, D.
    Granetto, C.
    Lo Nigro, C.
    Ferrero, M.
    Merlano, M. C.
    ANNALS OF ONCOLOGY, 2016, 27 : 9 - 9
  • [33] No Effect of Tumor-Infiltrating Lymphocytes (TILs) on Prognosis in Patients With Early Triple-Negative Breast Cancer: Validation of Recommendations by the International TILs Working Group 2014
    Park, Hyung Seok
    Heo, Ilyeong
    Kim, Jee Ye
    Kim, Sanghwa
    Nam, Sanggeun
    Park, Seho
    Kim, Seung Il
    JOURNAL OF SURGICAL ONCOLOGY, 2016, 114 (01) : 17 - 21
  • [34] Tumor-infiltrating lymphocytes (tils) density as prognostic determinant in stage ii colorectal cancer
    Ricci, V.
    Lo Nigro, C.
    Comino, A.
    Vivenza, D.
    Granetto, C.
    Ferrero, M.
    Lattanzio, L.
    Varamo, C.
    Merlano, M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [35] Tumor-infiltrating lymphocytes (TILs) density as prognostic determinant in stage II colorectal cancer
    Lo Nigro, C.
    Comino, A.
    Vivenza, D.
    Granetto, C.
    Ferrero, M.
    Lattanzio, L.
    Varamo, C.
    Ricci, V.
    Merlano, M. C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [36] ASO Visual Abstract: Tumor-Infiltrating Neutrophils after Neoadjuvant Therapy are Associated with Poor Prognosis in Esophageal Cancer
    Carlos S. Cabalag
    Owen W. J. Prall
    John Ciciulla
    Laurence A. Galea
    Niko Thio
    Madawa Jayawardana
    Trishe Y. M. Leong
    Julia V. Milne
    Kenji M. Fujihara
    Lynn Chong
    Michael W. Hii
    Gisela Mir Arnau
    Paul J. Neeson
    Wayne A. Phillips
    Cuong P. Duong
    Nicholas J. Clemons
    Annals of Surgical Oncology, 2023, 30 (3) : 1628 - 1629
  • [37] Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinomain situ
    Farolfi, Alberto
    Petracci, Elisabetta
    Serra, Luigi
    Ravaioli, Alessandra
    Bravaccini, Sara
    Ravaioli, Sara
    Tumedei, Maria Maddalena
    Ulivi, Paola
    Canale, Matteo
    Puccetti, Maurizio
    Falcini, Fabio
    Folli, Secondo
    Curcio, Annalisa
    Rocca, Andrea
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [38] The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition
    Loi, S.
    Michiels, S.
    Adams, S.
    Loibl, S.
    Budczies, J.
    Denkert, C.
    Salgado, R.
    ANNALS OF ONCOLOGY, 2021, 32 (10) : 1236 - 1244
  • [39] Interobserver Agreement Between Pathologists Assessing Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer Using Methodology Proposed by the International TILs Working Group
    Shannon K. Swisher
    Yun Wu
    Carlos A. Castaneda
    Genvieve R. Lyons
    Fei Yang
    Coya Tapia
    Xiuhong Wang
    Sandro A. A. Casavilca
    Roland Bassett
    Miluska Castillo
    Aysegul Sahin
    Elizabeth A. Mittendorf
    Annals of Surgical Oncology, 2016, 23 : 2242 - 2248
  • [40] Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: A Biomarker for Use Beyond Prognosis?
    Tsoutsou, Pelagia G.
    Bourhis, Jean
    Coukos, George
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (11) : 1297 - +